Federal Register / Vol. 70, No.
165 / Friday, August 26, 2005 / Notices
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Dale L. Birkle, PhD,
Scientific Review Administrator, NIH/
NCCAM, 6707 Democracy Blvd., Democracy
Two Building, Suite 401, Bethesda, MD
20892, (301) 451–6570, birkled@mail.nih.gov.
Dated: August 18, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17017 Filed 8–25–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group, Pediatrics Subcommittee.
Date: October 18–19, 2005.
Time: October 18, 2005, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday In Select Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rita Anand, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health, and Human Development, NIH, 9000
Rockville Pike, MSC 7510, 6100 Building,
Room 5B01, Bethesda, MD 10892, (301) 496–
1487, anandr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS.)
Dated: August 18, 2005.
Anthony M. Coelho, Jr.
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17010 Filed 8–25–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate jul<14>2003 16:18 Aug 25, 2005 Jkt 205001
50379
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, National
Institute of Neurological Disorders and
Stroke.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Neurological
Disorders and Stroke, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: September 18–20, 2005.
Closed: September 18, 2005, 7 p.m. to 10
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Open: September 19, 2005, 8:30 a.m. to
11:10 a.m.
Agenda: To discuss program planning and
program accomplishments.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room A, Rockville,
MD 20852.
Closed: September 19, 2005, 11:10 a.m. to
1:10 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room A, Rockville,
MD 20852.
Open: September 19, 2005, 1:10 p.m. to
4:30 p.m.
Agenda: To discuss program planning and
program accomplishments.
PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\26AUN1.SGM
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room A, Rockville,
MD 20852.
Closed: September 19, 2005, 4:30 p.m. to
5:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room A, Rockville,
MD 20852.
Closed: September 19, 2005, 6:30 p.m. to
9:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Closed: September 20, 2005, 8:30 a.m. to
11:30 a.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Story C. Landis, PhD,
Director, National Institute of Neurological
Disorders and Stroke, NIH, 31 Center Drive,
Building 31, Room 8A52, Bethesda, MD
20892, 301–496–9746,
landiss@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: August 18, 2005.
Anthony M. Coehlo,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17013 Filed 8–25–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
26AUN1
 50380 Federal Register / Vol. 70, No. 165 / Friday, August 26, 2005 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel Review of Research Program
Projects (P01s).
Date: September 27, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hawthorne Suites Hotel, 300
Meredith Drive, Research Triangle Park, NC
27713.
Contact Person: Janice B. Allen, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research and Training, Nat. Institute of
Environmental Health Science, P.O. Box
12233, MD EC–30/Room 3170B, Research
Triangle Park, NC 27709, (919) 541–7556.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: August 17, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17014 Filed 8–25–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Review of an Unsolicited
VerDate jul<14>2003 16:18 Aug 25, 2005 Jkt 205001
Revised Tyrosine Phosphatase Program
Project Application
Date: September 20, 2005.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
3118, Bethesda, MD 20817. (Telephone
Conference Call.)
Contact Person: Quirijn Vos, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, (301) 496–2550
qvos@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 19, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–17018 Filed 8–25–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Listing of Members of the
National Institutes of Health’s Senior
Executive Service Performance Review
Board (PRB)
The National Institutes of Health
(NIH) announces the persons who will
serve on the National Institutes of
Health’s Senior Executive Service
Performance Review Board. This action
is being taken in accordance with Title
5, U.S.C., 4314(c)(4), which requires that
members of performance review board
be appointed in a manner to ensure
consistency, stability, and objectivity in
performance appraisals, and requires
that notice of the appointment of an
individual to serve as a member be
published in the Federal Register.
The following persons will serve on
the NIH Performance Review Board,
which oversees the evaluation of
performance appraisals of NIH Senior
Executive Service (SES) members: Ms.
Colleen Barros (Chair), Dr. Norka Ruiz
Bravo, Dr. Michael Gottesman, Ms. Lynn
Hellinger, Dr. Barry Hoffer, Dr. Sharon
Hrynkow, Dr. Betsy Humphreys, Dr.
Raynard Kington, Dr. Lore Anne
McNicol, Dr. Marcelle Morrison-
Bogorad, Ms. Martha Pine, and Dr. Brent
Stanfield.
For further information about the NIH
Performance Review Board, contact the
Office of Human Resources, Workforce
Relations Division, National Institutes of
PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 E:\FR\FM\26AUN1.SGM
Health, Building 31/B3C07, Bethesda,
Maryland 20892, telephone (301) 402–
9203 (not a toll-free number).
Dated: August 16, 2005.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 05–17019 Filed 8–25–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Drug and Alcohol Services Information
System (DASIS) (OMB No. 0930–
0106)—Revision
The DASIS consists of three related
data systems: The Inventory of
Substance Abuse Treatment Services (I–
SATS); the National Survey of
Substance Abuse Treatment Services
(N–SSATS), and the Treatment Episode
Data Set (TEDS). The I–SATS includes
all substance abuse treatment facilities
known to SAMHSA. The N–SSATS is
an annual survey of all substance abuse
treatment facilities listed in the I–SATS.
The TEDS is a compilation of client-
level admission data and discharge data
submitted by States on clients treated in
facilities that receive State funds.
Together, the three DASIS components
provide information on the location,
scope and characteristics of all known
drug and alcohol treatment facilities in
the United States, the number of
persons in treatment, and the
characteristics of clients receiving
services at publicly-funded facilities.
This information is needed to assess the
nature and extent of these resources, to
identify gaps in services, to provide a
database for treatment referrals, and to
assess demographic and substance-
related trends in treatment. In addition,
SAMHSA and the State substance abuse
officials participating in SAMHSA’s
December 2004 meeting on National
Outcome Measures (NOMS) agreed that
several NOMS data elements to assess
the performance of the Substance Abuse
26AUN1